We therefore investigated the nature of the response of re-implanted WT and Eμ-Myc/cRel−/− lymphomas following acute treatment with the CHK1i, CCT244747, using a combination of (phospho)proteomic and RNA Seq analysis, as described (Supplementary Figure S2A) [19]. Here, MYC is linked to lymphoma.